Companies · Other Health Care

CDRH Holding, Inc.

NEW YORK · Other Health Care

Diligence memoA one-page analyst read on CDRH Holding, Inc. — recommendation, valuation, rhythm, risks.
$25.1M
Total raised · real
1
Rounds
3.6×
Latest step-up
Top 14%
Sector rank · raised
Series B
Latest stage · inferred · Fri Apr 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

CDRH Holding, Inc. looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.26× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.
  • Within the normal band (126% of peer median) for its niche.
Dormant
  • Last raise 11.2 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

CDRH Holding, Inc. behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
11.2 yr record
Peak capital year was 2015 with $70.5M across 5 filings.
Market position
ahead of 87% of Other Health Care peers
Capital scale is ahead of 87% of Other Health Care peers; modeled value is above 94% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Needs review
Row-level filing totals differ from canonical totals, so amendment/superseded filtering should be checked.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2015: $70.5M across 5 filings.
  • Largest single filing was $25.1M on 2015-04-24.
  • Filing rows sum to $70.5M, while canonical raised total is $25.1M; likely amendments/superseded rows are mixed into the detail view.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
  • Canonical filtering should be tightened before using row-level totals for diligence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

CDRH Holding, Inc. is one of 5377 Other Health Care companies tracked from NEW YORK. By capital raised it ranks in the upper tier (ahead of 87% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
12
Investors (latest)
2015
Year incorporated
2015-04-24
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2015-04-24 Raised $21M (real) Modeled valuation $457M (est)$21M$457MSeries B2015Series A · 2015-04-24 Raised $12M (real) Modeled valuation $237M (est)$12M$237MSeries A2015Series B · 2015-04-24 Raised $25M (real) Modeled valuation $556M (est)$25M$556MSeries B2015Seed · 2015-04-24 Raised $2.9M (real) Modeled valuation $71M (est)$2.9M$71MSeed2015Series A · 2015-04-24 Raised $10M (real) Modeled valuation $205M (est)$10M$205MSeries A2015+$12M+$25M+$2.9M+$10MCumulative $71M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$20.6M · 2015
Bridge · Series B-stage$11.8M · 2015smaller follow-on
Series B extension$25.1M · 2015
Bridge · Series B-stage$2.9M · 2015smaller follow-on
Bridge · Series B-stage$10.2M · 2015smaller follow-on

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$556.2M
Base estimate est.
$59.0M
Conservative case
$2.1B
Upside case
$139.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $457.3M · 2015-04-242015Series A · modeled $237.1M · 2015-04-24Series B · modeled $556.2M · 2015-04-24Seed · modeled $70.7M · 2015-04-24Series A · modeled $205.4M · 2015-04-242015
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
11.2 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
0 mo
Avg between rounds
Capital velocity
11.2 yr
On record since
2015
First round
5
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 10× above median
This company$25.1M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.6× of median
This company$10.2M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 25× above median
This company$556.2M
Sector median$22.1M

Raised more than 87% of sector peers (real $). Modeled value above 94% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #31 of 85.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Drynachan, Llc · Series B Raised $40.0M · modeled $886.2M (est)Vistria SHC Holdings, LLC · Series B Raised $39.7M · modeled $879.5M (est)Ebh Holding Company, Inc. · Series B Raised $70.9M · modeled $871.1M (est)Orthopediatrics Corp · Series B Raised $57.5M · modeled $864.0M (est)Assurerx Health, Inc · Series B Raised $51.5M · modeled $828.4M (est)IMRIS Inc. · Series B Raised $36.8M · modeled $816.0M (est)Remedy Partners, Inc. · Series B Raised $56.4M · modeled $795.3M (est)Hansen Medical Inc · Series B Raised $126.0M · modeled $775.4M (est)BCOM Investment Partners, LLC · Series B Raised $34.5M · modeled $764.3M (est)Michigan Critical Care Consultants, Inc. · Series B Raised $34.0M · modeled $753.2M (est)HY Holdings, Inc. · Series B Raised $33.0M · modeled $731.1M (est)Medical Solutions L.L.C. · Series B Raised $32.5M · modeled $720.0M (est)CDRH Holding, Inc. (this company) Raised $25.1M · modeled $556.2M (est)CDRH Holding, Inc.
CompanyStageRaised · realValue · estvs peer med.
Drynachan, LlcSeries B$40.0M$886.2M2.00×
Vistria SHC Holdings, LLCSeries B$39.7M$879.5M1.99×
Ebh Holding Company, Inc.Series B$70.9M$871.1M1.97×
Orthopediatrics CorpSeries B$57.5M$864.0M1.95×
Assurerx Health, IncSeries B$51.5M$828.4M1.87×
IMRIS Inc.Series B$36.8M$816.0M1.84×
Remedy Partners, Inc.Series B$56.4M$795.3M1.79×
Hansen Medical IncSeries B$126.0M$775.4M1.75×
BCOM Investment Partners, LLCSeries B$34.5M$764.3M1.72×
Michigan Critical Care Consultants, Inc.Series B$34.0M$753.2M1.70×
HY Holdings, Inc.Series B$33.0M$731.1M1.65×
Medical Solutions L.L.C.Series B$32.5M$720.0M1.62×
CDRH Holding, Inc. this companySeries B$25.1M$556.2M1.26×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$20.6M2015-04-24$114.7M$457.3M90%
Series A$11.8M2015-04-24$53.4M$237.1M90%
Series B$25.1M2015-04-24$139.5M$556.2M90%
Seed$2.9M2015-04-24$14.3M$70.7M85%
Series A$10.2M2015-04-24$46.3M$205.4M85%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$20.6M2015-04-24
    • First recorded raise — entered as Series B.
    • 25 investors on this round.
  2. Series A$11.8M2015-04-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 17 investors on this round.
  3. Series B$25.1M2015-04-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.1× larger than the prior — scaling up.
    • 36 investors on this round.
  4. Seed$2.9M2015-04-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 8.8× smaller than the prior — bridge or down round.
    • 3 investors on this round.
  5. Series A$10.2M2015-04-24
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 3.6× larger than the prior — scaling up.
    • 12 investors on this round.
Intelligence
Modeled next raise
$30.5M
Modeled next size est.range $19.8M$48.8M
3.6×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Theresa A. Gore14 other2015-04
Richard J. Schnall7 other2015-04
Derek L. Strum4 other2015-04
Kenneth A. Giuriceo4 other2015-04
Ravi A. Sachdev1 other2015-04
William A. Sanger1 other2015-04
Andrew A. Pardo2015-04
Jarrod A. Henshaw2015-04
John Dineen2015-04
John L. Dineen2015-04
Keith A. Koford2015-04
Kenneth A. Guiriceo2015-04
Registry & provenance

CDRH Holding, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1641491
SEC CIK
2015
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
CDRH Topco, Inc.Other Health CareSeries A$6.0M$120.9Mnetwork4 shared operators · same sector
CDRT Holding CorpOther Health CareSeries B$92.5M$729.2Mnetwork3 shared operators · same sector · same stage
Lotus Parent, Inc.Other Health CareSeries B$31.2M$690.4Mnetwork1 shared operator · same sector · same stage
Outdoor Home Services, Inc.Proptech / Real EstateSeries B$19.3M$186.3Mnetwork2 shared operators · same stage
Carestream Dental Alpha LtdHealthtechSeries A$5.4M$121.2Mnetwork3 shared operators
Peachy Corp.Other Health CareSeries B$25.1M$309.9Msame sector · same stage
AAC Holdings, Inc.Other Health CareSeries B$25.0M$553.9Msame sector · same stage
hCentive, Inc.Other Health CareSeries B$25.0M$553.9Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
CDHA Blocker Corp.Other Health CareSeries C$1.2B90%
TCH Group, Inc.Other Health CareSeries B$487.9M84%
Ebh Holding Company, Inc.Other Health CareSeries B$871.1M84%
OurHealth Holding Co LLCOther Health CareSeries A$87.1M84%
RMS Holding Company, LLCOther Health CareSeries A$97.6M83%
HeartFlow Holding, Inc.Other Health CareSeries D+$432.6M83%
VitalCare Holdco, Inc.Other Health CareSeed$4.9M83%
MedTrust Holdings, Inc.Other Health CareSeed$23.9M83%
Frequently asked
How much funding has CDRH Holding, Inc. raised?
CDRH Holding, Inc. has raised approximately $25.1M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is CDRH Holding, Inc.'s estimated valuation?
Provath's modeled valuation for CDRH Holding, Inc. is approximately $556.2M (modeled range $59.0M–$2.1B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is CDRH Holding, Inc. at?
CDRH Holding, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Apr 24.
What does CDRH Holding, Inc. do and where is it based?
CDRH Holding, Inc. operates in the Other Health Care sector, based in NEW YORK.
Explore related

See where CDRH Holding, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at CDRH Holding, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.